Venture capital fund · 2 deals
Venture capital firm investing in medical technology
Sydney, NSW
Every published round Bioshore took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Vexev | undisclosed | 7 Aug 2026 | $8.6m | Participant | SmartCompany, Startup Daily, This Week in Australian Startups, vexev.com, Ten13 portfolio | |
| Vexev | Seed | 6 Aug 2026 | $6m | Participant | ontargetish.com, evtoday.com, Ten13, datapile.co, vexev.com, Dealroom |
Companies Bioshore has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Vexev | AI-powered robotic ultrasound for vascular imaging | 6 Aug 2026, Seed | 2 | 0 |
Fund closes reported for Bioshore, as distinct from the investments it has made.
Companies Bioshore has backed that another company then bought. An exit for the holding, not a deal Bioshore did.
| Name | Role | Sources |
|---|---|---|
| Jeff Reid | General Partner | Dealroom, Wholesale Investor |
| David Bottomley | General Partner | Dealroom, Bioshore Ventures team page |
| Andrew Fox-Smith | General Partner | Dealroom, Bioshore Ventures team page |
Stories naming Bioshore. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Bioshore Ventures has wrapped up its first fund at $27 million with all capital committed, drawing 65 individual backers including three well-known investors, and has named four health-technology companies in its portfolio.
Eight Australian and New Zealand startups secured a combined $67.4 million in funding across various sectors including agtech, medtech, robotics, and fintech.
Also ontargetish.com
Weekly roundup: Firmus completes its $2.85b round; Procore acquires DroneDeploy; Atlassian rebounds while Canva cuts guidance; plus fresh raises for Zabidou, BioScout, Vexev, Enrola, Spacetalk and others.
Australian medical robotics firm Vexev has raised A$8.6 million to pursue FDA clearance and US commercialisation of its VxWave robotic ultrasound platform, with backing from existing and new investors.
Also Startup Daily·This Week in Australian Startups·SmartCompany
Roundup of eight Australian and New Zealand startups whose late-July funding totals $102 million across space capsules, medical devices, livestock breath analysis, sports analytics and AI crop forecasting.
Wholesale Investor's Steve Torso highlights Australian life sciences companies from the Emergence Preview Series, noting government grant funding, a Series A extension, venture co-investment, and a medtech company's ASX listing.
Also Wholesale Investor